Dean Tuck – Managing Director – Dreadnought Resources (ASX:DRE) is a highly active West Australian mineral explorer focused on finding the metals needed now and in the future.
Copyright 2023 – Finance News Network
Source: Finance News Network
20 Sep 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the FDA's award of orphan status and rare paediatric disease designation for the company's DUNP19 technology.
Read More04 Sep 2019 - Lithium Power International Limited (ASX:LPI) Executive Director - Corporate Finance, Richard Crookes, provides an update on the company's portfolio, starting with its key Maricunga lithium brine project in Northern Chile and hard rock lithium in WA.
Read More19 Dec 2023 - James Powell, General Manager - Investor Relations, Corporate Affairs and Sustainability for Rural Funds Management presents on the FY23 results of the Rural Funds Group (ASX:RFF).
Read More25 Nov 2019 - Lepidico (ASX:LPD) Managing Director, Joe Walsh provides an update on drill results from its recently acquired Rubicon and Helikon deposits in Namibia, L-Max Pilot Plant trial results and outlook.
Read More07 Nov 2023 - Elementos Limited (ASX:ELT) Managing Director Joe David provides an update on the company's tin projects in Tasmania and Spain.
Read More20 Feb 2024 - ABx Group: Pioneering rare earths exploration, fluoride breakthroughs, and bauxite triumphs in Tasmania.
Read More20 Nov 2023 - ABX Group (ASX:ABX) Managing Director Mark Cooksey speaks about rare earth resources, advancing sustainable aluminum production with promising growth for investors in the coming months.
Read More30 Jul 2024 - Joe David - CEO - Elementos (ASX:ELT) is committed to the safe and environmentally conscious exploration, development, and production of its global tin projects. The company owns two world class tin projects with large resource bases and significant exploration potential in mining-friendly jurisdictions.
Read More19 Aug 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress with the company's IMP761 drug, which is potentially active in more than 90% of autoimmune diseases.
Read More24 Nov 2020 - Imdex (ASX:IMD) Limited CEO Paul House discusses the company's financial update, outlook and strategy, and provides an introduction to its technology, which improves the productivity of drill rigs, data collection and analysis.
Read More
